BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 15069117)

  • 1. A prospective study of plasma C-peptide and colorectal cancer risk in men.
    Ma J; Giovannucci E; Pollak M; Leavitt A; Tao Y; Gaziano JM; Stampfer MJ
    J Natl Cancer Inst; 2004 Apr; 96(7):546-53. PubMed ID: 15069117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
    Kaaks R; Toniolo P; Akhmedkhanov A; Lukanova A; Biessy C; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E
    J Natl Cancer Inst; 2000 Oct; 92(19):1592-600. PubMed ID: 11018095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.
    Ma J; Pollak MN; Giovannucci E; Chan JM; Tao Y; Hennekens CH; Stampfer MJ
    J Natl Cancer Inst; 1999 Apr; 91(7):620-5. PubMed ID: 10203281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study.
    Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
    Int J Cancer; 2007 May; 120(9):2007-12. PubMed ID: 17266031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men.
    Ma J; Giovannucci E; Pollak M; Chan JM; Gaziano JM; Willett W; Stampfer MJ
    J Natl Cancer Inst; 2001 Sep; 93(17):1330-6. PubMed ID: 11535708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.
    Wei EK; Giovannucci E; Fuchs CS; Willett WC; Mantzoros CS
    J Natl Cancer Inst; 2005 Nov; 97(22):1688-94. PubMed ID: 16288122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.
    Lukanova A; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Arslan AA; Rinaldi S; Muti P; Lenner P; Koenig KL; Biessy C; Krogh V; Riboli E; Shore RE; Stattin P; Berrino F; Hallmans G; Toniolo P; Kaaks R
    Int J Cancer; 2004 Jan; 108(2):262-8. PubMed ID: 14639613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.
    Wei EK; Ma J; Pollak MN; Rifai N; Fuchs CS; Hankinson SE; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):850-5. PubMed ID: 15824155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.
    Chan JM; Stampfer MJ; Ma J; Gann P; Gaziano JM; Pollak M; Giovannucci E
    J Natl Cancer Inst; 2002 Jul; 94(14):1099-106. PubMed ID: 12122101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
    Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R
    J Natl Cancer Inst; 2000 Dec; 92(23):1910-7. PubMed ID: 11106682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition.
    Jenab M; Riboli E; Cleveland RJ; Norat T; Rinaldi S; Nieters A; Biessy C; Tjønneland A; Olsen A; Overvad K; Grønbaek H; Clavel-Chapelon F; Boutron-Ruault MC; Linseisen J; Boeing H; Pischon T; Trichopoulos D; Oikonomou E; Trichopoulou A; Panico S; Vineis P; Berrino F; Tumino R; Masala G; Peters PH; van Gils CH; Bueno-de-Mesquita HB; Ocké MC; Lund E; Mendez MA; Tormo MJ; Barricarte A; Martínez-García C; Dorronsoro M; Quirós JR; Hallmans G; Palmqvist R; Berglund G; Manjer J; Key T; Allen NE; Bingham S; Khaw KT; Cust A; Kaaks R
    Int J Cancer; 2007 Jul; 121(2):368-76. PubMed ID: 17372899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai.
    Probst-Hensch NM; Yuan JM; Stanczyk FZ; Gao YT; Ross RK; Yu MC
    Br J Cancer; 2001 Nov; 85(11):1695-9. PubMed ID: 11742490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis.
    Ma J; Li H; Giovannucci E; Mucci L; Qiu W; Nguyen PL; Gaziano JM; Pollak M; Stampfer MJ
    Lancet Oncol; 2008 Nov; 9(11):1039-47. PubMed ID: 18835745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein-3, and risk of colorectal cancer: a nested case-control study in the Japan Collaborative Cohort study.
    Suzuki S; Kojima M; Tokudome S; Suzuki K; Ozasa K; Ito Y; Inaba Y; Tajima K; Nakachi K; Watanabe Y; Tamakoshi A;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():45-9. PubMed ID: 20553081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like Growth Factor-1, IGF-binding Protein-3, C-peptide and Colorectal Cancer: a Case-control Study.
    Pankaj J; Kumari JR; Kim W; Lee SA
    Asian Pac J Cancer Prev; 2015; 16(9):3735-40. PubMed ID: 25987030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood levels of long-chain polyunsaturated fatty acids, aspirin, and the risk of colorectal cancer.
    Hall MN; Campos H; Li H; Sesso HD; Stampfer MJ; Willett WC; Ma J
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):314-21. PubMed ID: 17301265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Douglas JB; Silverman DT; Pollak MN; Tao Y; Soliman AS; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2298-306. PubMed ID: 20699371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.
    Yu H; Spitz MR; Mistry J; Gu J; Hong WK; Wu X
    J Natl Cancer Inst; 1999 Jan; 91(2):151-6. PubMed ID: 9923856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status.
    Inamura K; Song M; Jung S; Nishihara R; Yamauchi M; Lochhead P; Qian ZR; Kim SA; Mima K; Sukawa Y; Masuda A; Imamura Y; Zhang X; Pollak MN; Mantzoros CS; Harris CC; Giovannucci E; Fuchs CS; Cho E; Chan AT; Wu K; Ogino S
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26598515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405.
    Guercio BJ; Zhang S; Ou FS; Venook AP; Niedzwiecki D; Lenz HJ; Innocenti F; Pollak MN; Nixon AB; Mullen BC; O'Neil BH; Shaw JE; Polite BN; Benson AB; Atkins JN; Goldberg RM; Brown JC; O'Reilly EM; Mayer RJ; Blanke CD; Fuchs CS; Meyerhardt JA
    JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33426464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.